Mannkind Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1 Casper St, Danbury, Connecticut (CT) 06810-6903, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3005340341 · DUNS 099981040
FDA inspection history
Outcomes of closed FDA inspections at this site, every FDA program area; the official-action banner above considers Drug Quality Assurance inspections only.
- NAIDrug Quality Assurance2025-11-04
- VAIDrug Quality Assurance2021-08-06
- NAIDrug Quality Assurance2018-06-19
- VAIDrug Quality Assurance2013-05-17
- VAIDrug Quality Assurance2009-12-04
Drugs this plant is listed as making
1 distinct drugs across 7 products name this site for a manufacturing step (any MANUFACTURE-type role, API included). Counts are per distinct generic name (case-insensitive).
- Insulin HumanMannkind Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.